• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个包含六个 microRNA 的标志物可预测子宫内膜癌患者的生存情况。

A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma.

机构信息

Department of Pathogenobiology, College of Basic Medical Sciences, Jilin University, Changchun City, Jilin Province, China.

Department of Pathogenobiology, College of Basic Medical Sciences, Jilin University, Changchun City, Jilin Province, China.

出版信息

Curr Probl Cancer. 2019 Apr;43(2):167-176. doi: 10.1016/j.currproblcancer.2018.02.002. Epub 2018 Feb 21.

DOI:10.1016/j.currproblcancer.2018.02.002
PMID:29567372
Abstract

Uterine corpus endometrial carcinoma (UCEC) is one of the most common female gynecological malignant tumors that threaten women health seriously. MicroRNAs (miRNAs) has been proved to play critical roles in tumor pathogenesis and malignant progression. In this study, we aimed to explore a novel signature of microRNA expression for predicting the overall survival (OS) of patients with UCEC. The genome-wide miRNA expression profiles and relevant clinical characteristics of 348 patients with UCEC were downloaded from the Cancer Genome Atlas (TCGA) data portal and analyzed comprehensively. A total of 144 miRNAs were confirmed to be expressed differentially in tumor tissues. Among them, 6 miRNAs (hsa-mir-15a.MIMAT0000068, hsa-mir-142.MIMAT0000433, hsa-mir-142.MIMAT0000434, hsa-mir-3170.MIMAT0015045, hsa-mir-1976.MIMAT0009451, and hsa-mir-146a.MIMAT0000449) were validated to be significantly correlated with the OS of patients with UCEC. The risk indictor established by the 6-microRNA signature was proved be an independent prognostic factor (Hazard ratio = 0.391; 95% CI: 0.195-0.783; P = 0.008). In conclusion, we identified miRNAs that were correlated with the occurrence and progression of UCEC and established a 6-microRNA expression signature as a predictor for the OS of patients with UCEC.

摘要

子宫内膜癌(UCEC)是严重威胁妇女健康的最常见妇科恶性肿瘤之一。MicroRNAs(miRNAs)已被证明在肿瘤发病机制和恶性进展中发挥关键作用。在这项研究中,我们旨在探索一种新的 miRNA 表达谱,以预测 UCEC 患者的总生存率(OS)。从癌症基因组图谱(TCGA)数据门户下载了 348 例 UCEC 患者的全基因组 miRNA 表达谱和相关临床特征,并进行了综合分析。共有 144 个 miRNA 在肿瘤组织中被证实存在差异表达。其中,6 个 miRNA(hsa-mir-15a.MIMAT0000068、hsa-mir-142.MIMAT0000433、hsa-mir-142.MIMAT0000434、hsa-mir-3170.MIMAT0015045、hsa-mir-1976.MIMAT0009451 和 hsa-mir-146a.MIMAT0000449)被验证与 UCEC 患者的 OS 显著相关。由 6 个 miRNA 组成的风险指标被证明是独立的预后因素(危险比=0.391;95%CI:0.195-0.783;P=0.008)。总之,我们确定了与 UCEC 的发生和进展相关的 miRNAs,并建立了一个 6 个 miRNA 表达谱作为 UCEC 患者 OS 的预测指标。

相似文献

1
A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma.一个包含六个 microRNA 的标志物可预测子宫内膜癌患者的生存情况。
Curr Probl Cancer. 2019 Apr;43(2):167-176. doi: 10.1016/j.currproblcancer.2018.02.002. Epub 2018 Feb 21.
2
Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.建立与细胞坏死相关的子宫体子宫内膜癌预后模型。
Sci Rep. 2024 Feb 21;14(1):4257. doi: 10.1038/s41598-024-54651-3.
3
Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.基于多 RNA 类型的签名用于预测子宫体子宫内膜癌患者无复发生存。
DNA Cell Biol. 2020 Apr;39(4):615-630. doi: 10.1089/dna.2019.5148. Epub 2020 Feb 27.
4
A Five-microRNA Signature as Risk Stratification System in Uterine Corpus Endometrial Carcinoma.五 miRNA -signature 作为子宫体子宫内膜癌的风险分层系统。
Comb Chem High Throughput Screen. 2021;24(2):187-194. doi: 10.2174/1386207323999200730211227.
5
A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.一种七微小RNA表达特征可预测肝细胞癌的生存率。
PLoS One. 2015 Jun 5;10(6):e0128628. doi: 10.1371/journal.pone.0128628. eCollection 2015.
6
Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma.鉴定与子宫体子宫内膜癌生存和免疫微环境调节相关的 m7G 甲基化 miRNA 特征。
Biomed Res Int. 2022 Nov 23;2022:8776678. doi: 10.1155/2022/8776678. eCollection 2022.
7
Development of a 4-miRNA prognostic signature for endometrial cancer.开发用于子宫内膜癌的 4 个 miRNA 预后签名。
Medicine (Baltimore). 2022 Oct 14;101(41):e30974. doi: 10.1097/MD.0000000000030974.
8
LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.LYL1 基因扩增预示着子宫体子宫内膜癌患者生存不良:癌症基因组图谱数据分析。
BMC Cancer. 2018 May 2;18(1):494. doi: 10.1186/s12885-018-4429-z.
9
An miRNA signature associated with tumor mutation burden in endometrial cancer.与子宫内膜癌肿瘤突变负担相关的 miRNA 特征。
Biosci Rep. 2020 Nov 27;40(11). doi: 10.1042/BSR20203398.
10
A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.一种 14-甲基化驱动的差异表达 RNA 作为预测子宫体子宫内膜癌患者总生存期的标志物。
DNA Cell Biol. 2020 Jun;39(6):975-991. doi: 10.1089/dna.2019.5313. Epub 2020 May 12.

引用本文的文献

1
Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry.子宫体子宫内膜癌新型生物标志物的研究:通过RT-qPCR和免疫组织化学进行计算机分析及临床标本验证
Am J Cancer Res. 2023 Sep 15;13(9):4376-4400. eCollection 2023.
2
Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer-Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects.循环 miRNA 作为子宫内膜癌早期诊断的工具——对保留生育功能过程的影响:临床、生物学和法律方面。
Int J Mol Sci. 2023 Jul 12;24(14):11356. doi: 10.3390/ijms241411356.
3
MicroRNAs as Potential Biomarkers in Gynecological Cancers.
微小RNA作为妇科癌症的潜在生物标志物
Biomedicines. 2023 Jun 13;11(6):1704. doi: 10.3390/biomedicines11061704.
4
The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions.性激素和 microRNAs 在子宫内膜癌中的相互作用:当前的认识和未来的方向。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1166948. doi: 10.3389/fendo.2023.1166948. eCollection 2023.
5
Construction of a miRNA-Based Nomogram Model to Predict the Prognosis of Endometrial Cancer.构建基于微小RNA的列线图模型以预测子宫内膜癌的预后
J Pers Med. 2022 Jul 17;12(7):1154. doi: 10.3390/jpm12071154.
6
A 4-miRNA signature act as a novel prognostic biomarker in patients with Sarcoma.一种4- miRNA特征作为肉瘤患者的新型预后生物标志物。
Transl Cancer Res. 2019 Aug;8(4):1412-1422. doi: 10.21037/tcr.2019.07.46.
7
Role of alternative splicing events in endometrial cancer prognosis.可变剪接事件在子宫内膜癌预后中的作用。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Jul 28;46(7):680-688. doi: 10.11817/j.issn.1672-7347.2021.190763.
8
Immune and Metabolic Dysregulated Coding and Non-coding RNAs Reveal Survival Association in Uterine Corpus Endometrial Carcinoma.免疫与代谢失调的编码和非编码RNA揭示子宫体子宫内膜癌的生存关联
Front Genet. 2021 Jun 24;12:673192. doi: 10.3389/fgene.2021.673192. eCollection 2021.
9
Upregulation of microRNA miR-141-3p and its prospective targets in endometrial carcinoma: a comprehensive study.miR-141-3p 在子宫内膜癌中的上调及其潜在靶基因的综合研究。
Bioengineered. 2021 Dec;12(1):2941-2956. doi: 10.1080/21655979.2021.1943111.
10
Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.生物信息学分析鉴定子宫内膜癌免疫微环境中与预后相关的基因。
Sci Rep. 2021 Jun 15;11(1):12608. doi: 10.1038/s41598-021-92091-5.